Literature DB >> 10081683

Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.

S S Rotun1, V McMath, D J Schoonmaker, P S Maupin, F C Tenover, B C Hill, D M Ackman.   

Abstract

A Staphylococcus aureus isolate with reduced susceptibility to vancomycin was obtained from a dialysis patient with a fatal case of bacteremia. Comparison of the isolate with two methicillin-resistant S. aureus (MRSA) isolated obtained from the same patient 4 months earlier suggests that the S. aureus with reduced susceptibility to vancomycin emerged from the MRSA strain with which the patient was infected. Atypical phenotypic characteristics, including weak or negative latex-agglutination test results, weak or negative-slide coagulase test results, heterogeneous morphologic features, slow rate of growth, and vancomycin susceptibility (by disk diffusion test) were observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081683      PMCID: PMC2627701          DOI: 10.3201/eid0501.990118

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  4 in total

1.  Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-08-22       Impact factor: 17.586

2.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

3.  Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.

Authors:  F C Tenover; M V Lancaster; B C Hill; C D Steward; S A Stocker; G A Hancock; C M O'Hara; S K McAllister; N C Clark; K Hiramatsu
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility.

Authors:  R S Daum; S Gupta; R Sabbagh; W M Milewski
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

  4 in total
  40 in total

1.  Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates.

Authors:  S Boyle-Vavra; S K Berke; J C Lee; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.

Authors:  Y Ike; Y Arakawa; X Ma; K Tatewaki; M Nagasawa; H Tomita; K Tanimoto; S Fujimoto
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus.

Authors:  H Maki; K Miura; Y Yamano
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance.

Authors:  Susan Boyle-Vavra; Mamatha Challapalli; Robert S Daum
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

5.  Molecular epidemiology of clinical isolates of methicillin-resistant Staphylococcus aureus in Taiwan.

Authors:  Yhu-Chering Huang; Lin-Hui Su; Tsu-Lan Wu; Chun-Eng Liu; Tzuu-Guang Young; Po-Yen Chen; Po-Ren Hseuh; Tzou-Yien Lin
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

6.  Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.

Authors:  R F Pfeltz; V K Singh; J L Schmidt; M A Batten; C S Baranyk; M J Nadakavukaren; R K Jayaswal; B J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

7.  Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid.

Authors:  M Souli; K Pontikis; Z Chryssouli; I Galani; H Giamarellou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

8.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

9.  VISA, hetero-VISA and VRSA: the end of the vancomycin era?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis       Date:  2002-09

10.  Coupling immunomagnetic separation on magnetic beads with matrix-assisted laser desorption ionization-time of flight mass spectrometry for detection of staphylococcal enterotoxin B.

Authors:  Gitta Schlosser; Petr Kacer; Marek Kuzma; Zoltán Szilágyi; Alida Sorrentino; Carla Manzo; Rosa Pizzano; Livia Malorni; Gabriella Pocsfalvi
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.